From a molecular pharmacy standpoint, Relafen 750 ( Naproxen Sodium ) presents a fascinating case study in medication action. Its mechanism of action primarily involves the inhibition of cyclooxygenase ( COX enzymes ) enzymes, particularly COX-2 , leading to a decrease in the synthesis of inflammatory mediators. This focused inhibition accounts for